An Introduction to Regulatory Submissions in Clinical Trials [Video]

Regulatory submissions in clinical trials are the formal packages of documents and data sent to regulators to support activities such as trial start, protocol changes, safety reporting, and later marketing applications. This explainer breaks down how submissions are reviewed, why early technical checks matter, and where preventable issues can slow a programme before the scientific review begins.

WHAT THIS VIDEO COVERS
• What a regulatory submission includes in a clinical trial context
• The difference between technical validation, completeness checks, and scientific questions
• Common submission types, including CTAs, INDs, amendments, DSURs, and updated Investigator’s Brochures
• Why protocol changes can create inconsistencies across dependent documents
• How publishing dry runs, version control, and metadata checks can reduce avoidable delays
• What teams should prepare for after submission, including evidence-backed responses to regulator questions

Good submission work depends on clarity, control, and disciplined document and data handling. Locking versions, checking dependencies, and running technical validation before the final freeze can help teams avoid late rework and keep the submission package coherent.

At Quanticate, our clinical data, programming, medical writing, and regulatory support teams work with sponsors across clinical trials and regulated development.